|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: tolterodine tartrate
|
Tentative approvals for TOLTERODINE TARTRATE
| ||||||||||||||||||||||||||||||||||||
Clinical Trials for: tolterodine tartrateTolterodine Drug Use Investigation.(Post Marketing Commitment Plan) Status: Completed Condition: Overactive Bladder Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder Status: Completed Condition: Overactive Bladder Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients Status: Completed Condition: Overactive Bladder Pharmacokinetics and Relative Bioavailability Study Status: Completed Condition: Urinary Bladder, Overactive Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects Status: Completed Condition: Healthy Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) Status: Active, not recruiting Condition: BPH Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||||||||||||||||||||||||
Litigation for: TOLTERODINE | |||||||||||||||||||||||||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 6,911,217*PED | Y | Y | <disabled> | TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 6,770,295*PED | Y | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 6,630,162*PED | Y | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 5,382,600*PED | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
